Wearable Injectors Market by Type (Off-Body, On-Body, Accessories), Application (Diabetes, Oncology, Cardiovascular) End Users (Clinics, Home Care Setting, Hospitals) - Analysis & Forecast 2019-2030
Report ID : 13 | Published Date : Jan 2019 | Pages : 150 | Region : Global | Report Code : MD-07
Wearable Injectors Market Overview and Introduction
Wearable Injectors Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030. The global wearable injectors market is estimated to be over US$ 4.5 Bn in 2017. It is anticipated to grow at a double digit CAGR from 2019 to 2030. The global wearable injectors market is segmented by type, application, end user and region.
Wearable Injectors are drug delivery devices that are used in injecting small dose of drug into the body. The dosage size and time of dosage is regulated by the device and is also auto injected in the body according the metabolism of the body. Wearable devices monitor the body regulation and provide reports.
The global wearable injectors market is driven by technologically advanced products & introduction of new cost effective products in the market, and rise in number of diabetes and chronic diseases patients. However, high cost related to wearable injectors & lacks of reimbursement policies for wearable injector are some of the factors likely to restrain the market to certain extent.
Wearable Injectors Market by Type
On the basis of type, the wearable injectors market is segmented off-body, on-body and accessories. The on-body wearable injectors market is estimated to account for the largest share of the market. The large share of the market can be attributed to rising demand for wearable devices.
Wearable Injectors Market by Applications
Based on application the market can be segmented into diabetes, oncology, cardiovascular disease and other application. Diabetes segment is expected to account for the largest share of the market. The growth of the segment can be attributed to factors such as growing number of diabetic patient globally and need for continuous glucose monitoring devices & insulin pump for diabetic patient are some of the factor driving the growth of the market
Wearable Injectors Market by End Users
Based on the end users, the market is segmented into hospitals, clinics and homecare setting and other end users. The hospitals segment is estimated to account for the largest share of the global wearable injectors market.
Wearable Injectors Market by Regions
The global Wearable Injectors market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of wearable injectors, followed by Europe and Asia Pacific. North America will continue to dominate the global wearable injectors market in the forecast period owing to rising prevalence of diabetes and cancer diseases and availability of technology advance wearable products. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as high number of diabetic patient India and China and growing healthcare industry is likely to boost the market in coming years. The high cost of wearable injectors, and lack of reimbursement policies & regulations may restrain market growth to a certain extent.
Wearable Injectors Market Promoinent Players
The prominent players in the global wearable injectors market are Medtronic, Insulet Corporation, Tandem Diabetes Care, Amgen, Ypsomed, Becton Dickinson and Company, Enable Injections, Debiotech, Inc., Cellnovo, and Valeritas among others.